Is surgery for retroperitoneal sarcoma at "low-volume" hospitals a bad idea?

Affiliations

Free article

Editorial

Mary E Putt. Cancer. 2018.

Free article

. 2018 Dec 1;124(23):4447-4451.

doi: 10.1002/cncr.31750. Epub 2018 Oct 14.

¹ Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

No abstract available

Comment on

A call to action: Why sarcoma surgery needs to be centralized.
Raut CP, Bonvalot S, Gronchi A. Raut CP, et al. Cancer. 2018 Dec 1;124(23):4452-4454. doi: 10.1002/cncr.31749. Epub 2018 Oct 14. Cancer. 2018. PMID: 30317538 No abstract available.
Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Keung EZ, et al. Cancer. 2018 Dec 1;124(23):4495-4503. doi: 10.1002/cncr.31699. Epub 2018 Oct 14. Cancer. 2018. PMID: 30317543 Free PMC article.